Actively Recruiting
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Led by AstraZeneca · Updated on 2026-04-21
130
Participants Needed
17
Research Sites
219 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To fulfil the post-approval commitment of MFDS to conduct post-marketing surveillance, this study is designed to assess the known safety profile, identify previously unsuspected adverse reactions and to evaluate the effectiveness of Capivasertib under conditions of routine daily medical practice in Korea.
CONDITIONS
Official Title
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients eligible for and treated with the study drug according to the approved label in South Korea
- Patients who provide signed and dated written informed consent, either personally or through a legally acceptable representative.
You will not qualify if you...
- Participation in any interventional trial during the treatment of the study drug
- Other off-label indications according to the approved label in South Korea
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Research Site
Busan, South Korea, 34084
Not Yet Recruiting
2
Research Site
Busan, South Korea, 49241
Not Yet Recruiting
3
Research Site
Busan, South Korea, 49267
Actively Recruiting
4
Research Site
Daejeon, South Korea, 34943
Not Yet Recruiting
5
Research Site
Daejeon, South Korea, 35015
Actively Recruiting
6
Research Site
Goyang-si, South Korea, 10380
Actively Recruiting
7
Research Site
Goyang-si, South Korea, 10408
Actively Recruiting
8
Research Site
Guri-si, South Korea, 11923
Actively Recruiting
9
Research Site
Incheon, South Korea, 21565
Actively Recruiting
10
Research Site
Incheon, South Korea, 22332
Actively Recruiting
11
Research Site
Seongnam-si, South Korea, 13620
Not Yet Recruiting
12
Research Site
Seoul, South Korea, 02841
Actively Recruiting
13
Research Site
Seoul, South Korea, 03722
Actively Recruiting
14
Research Site
Seoul, South Korea, 06273
Not Yet Recruiting
15
Research Site
Seoul, South Korea, 06591
Actively Recruiting
16
Research Site
Suwon, South Korea, 16499
Actively Recruiting
17
Research Site
Uijeongbu-si, South Korea, 11765
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here